These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 10675090)
61. Effects of renal replacement therapy on renal recovery after acute kidney injury. Schneider AG; Bagshaw SM Nephron Clin Pract; 2014; 127(1-4):35-41. PubMed ID: 25343818 [TBL] [Abstract][Full Text] [Related]
62. Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Albright RC; Smelser JM; McCarthy JT; Homburger HA; Bergstralh EJ; Larson TS Mayo Clin Proc; 2000 Nov; 75(11):1141-7. PubMed ID: 11075743 [TBL] [Abstract][Full Text] [Related]
63. Biocompatibility of the polyamide membranes. Deppisch R; Betz M; Hänsch GM; Rauterberg EW; Ritz E Contrib Nephrol; 1992; 96():26-46. PubMed ID: 1740049 [No Abstract] [Full Text] [Related]
64. The role of platelet-activating factor in the biocompatibility of hemodialysis membranes. Tetta C; Haeffner-Cavaillon N; Navino C; David S; Franceschi C; Mariano F; Camussi G Adv Exp Med Biol; 1996; 416():243-8. PubMed ID: 9131156 [No Abstract] [Full Text] [Related]
71. Clinical Relevance of Dialysis Membrane Biocompatibility. Proceedings of a conference. Miami, USA, February 1995. Nephrol Dial Transplant; 1995; 10 Suppl 10():1-59. PubMed ID: 8927289 [No Abstract] [Full Text] [Related]
72. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes. Krieter DH; Lemke HD; Wanner C Nephrol Dial Transplant; 2006 Feb; 21(2):546; author reply 546. PubMed ID: 16249195 [No Abstract] [Full Text] [Related]
73. Biocompatibility aspects of chronic hemodialysis and their clinical relevance. Wauters JP Clin Nephrol; 1995 Nov; 44 Suppl 1():S19-23. PubMed ID: 8608656 [TBL] [Abstract][Full Text] [Related]
75. Arachidonic acid metabolites as biocompatibility parameters for cellulosic membranes. Boran M; Bozdayi M; Cetin S Nephrol Dial Transplant; 1999 Jul; 14(7):1804-5. PubMed ID: 10435906 [No Abstract] [Full Text] [Related]
76. Dialysis modalities in patients with acute renal failure. Ozdemir FN; Akcay A; Haberal M Nephrol Dial Transplant; 2001; 16 Suppl 6():18-20. PubMed ID: 11568230 [No Abstract] [Full Text] [Related]
77. Serum angiotensin-converting enzyme is not an indicator of dialyzer membrane biocompatibility. Docci D; Turci F; Baldrati L; Delvecchio C Nephron; 1988; 48(4):335. PubMed ID: 2834657 [No Abstract] [Full Text] [Related]
78. Effect of the dialysis membrane in the treatment of patients with acute renal failure. Hakim RM; Wingard RL; Parker RA N Engl J Med; 1994 Nov; 331(20):1338-42. PubMed ID: 7935703 [TBL] [Abstract][Full Text] [Related]
79. Biocompatible dialysis membranes: do they matter? Kooman JP; Leunissen KM Neth J Med; 1998 May; 52(5):156-9. PubMed ID: 9652153 [No Abstract] [Full Text] [Related]
80. The use of biocompatible dialysis membranes in acute renal failure. Himmelfarb J; Hakim RM Adv Ren Replace Ther; 1997 Apr; 4(2 Suppl 1):72-80. PubMed ID: 9113243 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]